Top Tech Companies (1,916)
Don't see your company?
Create a company profile
.jpg)
Frontier Science is a not-for-profit research organization founded by distinguished Harvard professor Dr. Marvin Zelen in 1975, now known internationally as a trusted data management and statistical center. We collaborate with universities, research networks, pharmaceutical companies, and other industry organizations in all phases of clinical trials and health research.
Dimension Inx is the architect of regenerative microenvironments. Our materials give the body a blueprint to heal itself. We take a materials-centric approach to solving patient needs. By creating structures that emulate the body’s microenvironment, we elicit an immediate regenerative response. We design for biofunctionality and manufacturability. Our platform is highly adaptable and not limited to any single material. Our collaborative studio approach allows us to co-create a lasting advantage by partnering with leading product and R&D organizations. Contact us to accelerate the development of new regenerative solutions today.
Diatherix Laboratories provides clinical laboratory services for the detection of infectious disease pathogens.
Arcturus Therapeutics is a global late stage-clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases
Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases. We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Our product portfolio is designed to make a significant impact on neurodegenerative and rare peripheral amyloid diseases, which affect millions of people and their families worldwide. We leverage insights around neurological dysfunction and the biology of misfolded proteins to develop novel therapeutic solutions that directly target pathogenic proteins in order to change the course of devastating diseases. At Prothena, our success is driven by our people. We are dedicated to attracting individuals who share our vision to improve human health by putting patients first. Our shared humanity drives a passionate and unwavering commitment to apply high scientific rigor toward developing innovative new therapies for patients. We have ambitious goals and take every aspect of our mission seriously, while enjoying the journey. Our values connect us – you will see and feel them come to life in all we do – together
WinSanTor Inc. is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies.
Nanobot Medical Animation delivers digital solutions for the pharmaceutical, biotech and medical device industries.
High Quality Pharmaceuticals from Yeast.
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. In 2014, the company was spun out of Adam Abate’s lab for high-throughput biology at the University of California, San Francisco (UCSF). Mission Bio’s precision genomics platform is based on the pioneering droplet microfluidics work of Abate and his team. Our mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine. Visit missionbio.com to learn more.
At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK’s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Today, Orchard is advancing a pipeline spanning pre-clinical, clinical and commercial stage HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist. Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit www.orchard-tx.com,
Recros Medica is a medical device company developing technologies to treat skin laxity and focal aesthetic contour deformities.
Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the human body will respond to treatment - something that previously required costly animal testing and human trials to determine. The functional, interconnected, human in vitro platform, provides preclinical insight into the efficacy and toxicity of novel therapeutics. Ultimately, Hesperos’ Human-on-a-Chip is reducing the need for animal testing in drug discovery while enabling research into rare diseases previously considered untreatable.
Medisyn Technologies is a unique bioactive compound design and discovery company for novel pharmaceuticals, nutraceuticals and animal health products. Through its proprietary Forward Engineering™ technology platform, Medisyn makes bioactive compound discovery faster, more predictable and less expensive. Based on molecular topology, Medisyn’s platform enables the discovery and design of novel, diverse and unexpected compounds in new chemical classes that meet exact parameters for a specific therapeutic use. By compressing design and discovery time from years to months and optimizing lead candidates, Medisyn’s novel approach enables customers to reduce risk, improve probability of success and control costs associated with the traditional lead discovery process.
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Talis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings. Testing for COVID-19 is in high demand. Learn more about our product options. GenBody COVID-19 Ag Test Minimize disruptions with high-volume SARS-CoV-2 antigen testing and results in 15 minutes Learn more: https://talisbio.com/genbody-covid-19-antigen-test/ TALIS ONE™ COVID-19 TEST SYSTEM Rapid point-of-care COVID-19 test that enables highly sensitive SARS-CoV-2 RNA detection from nasal mid-turbinate swabs in less than 30 minutes. With its dual-gene target design, test sensitivity and inclusivity of variants are optimized. Learn more: https://talisbio.com/talis-one-covid-19-test-system/ Our visionary team combines depth of experience with passion to deliver a pioneering solution to infectious disease diagnostics. Infectious disease treatment today is largely guideline-driven: treat patients with similar symptoms the same. Unfortunately, similar symptoms can often have very different causes. Our tests will enable caregivers to know within minutes, the cause of illness, as well as which medications will be effective for their patient, empowering them to provide individualized care rather than broad, guideline-dictated treatments. From the doctor’s office to the hospital bedside to remote care settings, we are re-defining the treatment of infectious diseases.
Emerging Therapy Solutions® (ETS) was founded in 2018 by industry veterans of managed care solutions, healthcare biotech and transplant to help healthcare payers manage the risks associated with high-cost therapies for rare and complex conditions. ETS acquired LifeTrac in 2020, bringing over 30 years of experience in bone marrow and solid organ transplants, plus provider relationships and agreements, to complement Emerging Therapy Solutions’ expertise in cell and gene therapies. The integrated business offers payers a comprehensive suite of services for solid organ and bone marrow transplants, cell and gene therapies, and other highly specialized therapies.
Gatehouse Bio is developing therapeutics that correct the effects of disease-driving mutations in small RNA genes. We believe there is an RNA code that can treat every disease. Our mission is to find that code and use it to develop effective therapeutics. Our platform is the first to use AI to discover small RNA mutations and design oligonucleotides that crack a disease’s code. Our pipeline and partnerships are focused on developing drugs for therapeutic areas with known heterogeneity such as fibrosis, inflammation and neurodegeneration. With every single code we break, we unlock the potential to improve the lives of many.
Biopeptide company offers design, synthesis, and production of peptides using Fmoc solid phase and solution phase technology.
Cardiff Oncology is develops drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers.
eTeki is where the world goes to qualify talent. Our award winning technical interviews-as-a-service platform enables organizations across the globe hire the best tech talent, fast. eTeki is poised to disrupt the way IT candidates are hired by giving any company the ability to screen large numbers of tech talent quickly. Unlike conventional video interviewing tools available today, eTeki is powered by a network of trained and certified IT specialists offering services to assess each candidate’s technical skills in real time. Our network of over 5000 expert interviewers have expertise in every stack and provide an unbiased assessment of technical skills and behavioral fit, with an extensive candidate report and video in 24 hours or less. Full and self service options are available. eTeki lets organizations save money, reduce bad hires, and hire the best talent for the job. eTeki's leadership team has over 100 years combined experience with marketplaces, tech screening and hiring. Our mission is to supply the world with interviews-as-a-service to scale and optimize technical hiring.
